These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 30283362)
1. A Review of the Inhibition of the Mitochondrial ATP Synthase by IF1 García-Aguilar A; Cuezva JM Front Physiol; 2018; 9():1322. PubMed ID: 30283362 [TBL] [Abstract][Full Text] [Related]
2. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival. García-Bermúdez J; Cuezva JM Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the H Esparza-Moltó PB; Nuevo-Tapioles C; Cuezva JM Cell Mol Life Sci; 2017 Jun; 74(12):2151-2166. PubMed ID: 28168445 [TBL] [Abstract][Full Text] [Related]
4. PKA Phosphorylates the ATPase Inhibitory Factor 1 and Inactivates Its Capacity to Bind and Inhibit the Mitochondrial H(+)-ATP Synthase. García-Bermúdez J; Sánchez-Aragó M; Soldevilla B; Del Arco A; Nuevo-Tapioles C; Cuezva JM Cell Rep; 2015 Sep; 12(12):2143-55. PubMed ID: 26387949 [TBL] [Abstract][Full Text] [Related]
5. The ATPase Inhibitory Factor 1 (IF1) Contributes to the Warburg Effect and Is Regulated by Its Phosphorylation in S39 by a Protein Kinase A-like Activity. Cuezva JM; Domínguez-Zorita S Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473373 [TBL] [Abstract][Full Text] [Related]
6. The Role of Mitochondrial H Esparza-Moltó PB; Cuezva JM Front Oncol; 2018; 8():53. PubMed ID: 29564224 [TBL] [Abstract][Full Text] [Related]
7. The Mitochondrial ATP Synthase/IF1 Axis in Cancer Progression: Targets for Therapeutic Intervention. Domínguez-Zorita S; Cuezva JM Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568591 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype. Sánchez-Cenizo L; Formentini L; Aldea M; Ortega AD; García-Huerta P; Sánchez-Aragó M; Cuezva JM J Biol Chem; 2010 Aug; 285(33):25308-13. PubMed ID: 20538613 [TBL] [Abstract][Full Text] [Related]
9. The Multifaceted ATPase Inhibitory Factor 1 (IF1) in Energy Metabolism Reprogramming and Mitochondrial Dysfunction: A New Player in Age-Associated Disorders? Gore E; Duparc T; Genoux A; Perret B; Najib S; Martinez LO Antioxid Redox Signal; 2022 Aug; 37(4-6):370-393. PubMed ID: 34605675 [No Abstract] [Full Text] [Related]
10. The ATPase Inhibitory Factor 1 is a Tissue-Specific Physiological Regulator of the Structure and Function of Mitochondrial ATP Synthase: A Closer Look Into Neuronal Function. Domínguez-Zorita S; Romero-Carramiñana I; Cuezva JM; Esparza-Moltó PB Front Physiol; 2022; 13():868820. PubMed ID: 35620611 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial H Formentini L; Ryan AJ; Gálvez-Santisteban M; Carter L; Taub P; Lapek JD; Gonzalez DJ; Villarreal F; Ciaraldi TP; Cuezva JM; Henry RR Diabetologia; 2017 Oct; 60(10):2052-2065. PubMed ID: 28770317 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of oxidative phosphorylation in the liver by expression of the ATPase inhibitory factor 1 induces a tumor-promoter metabolic state. Santacatterina F; Sánchez-Cenizo L; Formentini L; Mobasher MA; Casas E; Rueda CB; Martínez-Reyes I; Núñez de Arenas C; García-Bermúdez J; Zapata JM; Sánchez-Aragó M; Satrústegui J; Valverde ÁM; Cuezva JM Oncotarget; 2016 Jan; 7(1):490-508. PubMed ID: 26595676 [TBL] [Abstract][Full Text] [Related]
13. Generation of mitochondrial reactive oxygen species is controlled by ATPase inhibitory factor 1 and regulates cognition. Esparza-Moltó PB; Romero-Carramiñana I; Núñez de Arenas C; Pereira MP; Blanco N; Pardo B; Bates GR; Sánchez-Castillo C; Artuch R; Murphy MP; Esteban JA; Cuezva JM PLoS Biol; 2021 May; 19(5):e3001252. PubMed ID: 33983919 [TBL] [Abstract][Full Text] [Related]
14. F-ATP synthase inhibitory factor 1 regulates metabolic reprogramming involving its interaction with c-Myc and PGC1α. Guo L; Gu Z Front Oncol; 2023; 13():1207603. PubMed ID: 37469400 [TBL] [Abstract][Full Text] [Related]
15. Tissue-specific expression and post-transcriptional regulation of the ATPase inhibitory factor 1 (IF1) in human and mouse tissues. Esparza-Moltó PB; Nuevo-Tapioles C; Chamorro M; Nájera L; Torresano L; Santacatterina F; Cuezva JM FASEB J; 2019 Feb; 33(2):1836-1851. PubMed ID: 30204502 [TBL] [Abstract][Full Text] [Related]
16. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells. Solaini G; Sgarbi G; Baracca A Biochem Soc Trans; 2021 Apr; 49(2):815-827. PubMed ID: 33929490 [TBL] [Abstract][Full Text] [Related]
17. IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype. Domínguez-Zorita S; Romero-Carramiñana I; Santacatterina F; Esparza-Moltó PB; Simó C; Del-Arco A; Núñez de Arenas C; Saiz J; Barbas C; Cuezva JM Cell Death Dis; 2023 Jul; 14(7):413. PubMed ID: 37433784 [TBL] [Abstract][Full Text] [Related]
18. The pro-oncogenic protein IF Sgarbi G; Righetti R; Del Dotto V; Grillini S; Giorgio V; Baracca A; Solaini G Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166879. PubMed ID: 37689158 [TBL] [Abstract][Full Text] [Related]
19. Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers. Sánchez-Aragó M; Formentini L; Martínez-Reyes I; García-Bermudez J; Santacatterina F; Sánchez-Cenizo L; Willers IM; Aldea M; Nájera L; Juarránz A; López EC; Clofent J; Navarro C; Espinosa E; Cuezva JM Oncogenesis; 2013 Apr; 2(4):e46. PubMed ID: 23608753 [TBL] [Abstract][Full Text] [Related]
20. The role of the ATPase inhibitor factor 1 (IF Sgarbi G; Barbato S; Costanzini A; Solaini G; Baracca A Biochim Biophys Acta Bioenerg; 2018 Feb; 1859(2):99-109. PubMed ID: 29097244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]